AstraZeneca.
company in Osaka, Japan
- Reports this week
- 0
- Active events
- 0
- Connections
- 22
What's happening
One to three months ago
-
Corporate stocks, including AstraZeneca and CMG, reacted to analyst ratings and U.S. Treasury buyback plans.Some support2 reports
-
Bristol-Myers Squibb and AstraZeneca announced a collaboration on advanced cancer drug development.Some support1 report
-
Barclays and AstraZeneca are noted as major listed companies amid positive market sentiment for miners and lenders.Some support1 report
-
Citibank upgraded its price target while Deutsche Bank maintained a negative rating for AstraZeneca.Some support1 report
-
A late-stage trial failure involving a partner of AstraZeneca was announced, while the FDA concurrently approved Tryngolza for severe hypertriglyceridemia.Some support3 reports
-
GSK and AstraZeneca announce a partnership aimed at gaining access to the mainland China market.Some support1 report
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around AstraZeneca this week
News at the entities that move AstraZeneca most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves AstraZeneca
-
Morgan Stanley OperationalFinancial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Moves AstraZeneca
-
Daiichi Sankyo OperationalThe Supreme Court disposed of the petition concerning the legal dispute between Fortis Healthcare and Daiichi Sankyo.Moves AstraZeneca
-
Iran Shared contextA bill, named after Lindsey Graham, has been signed authorizing sanctions on Russian officials and energy, while also extending sanctions on Iran's energy and weapons sectors.Moves AstraZeneca
-
Bristol-Myers Squibb OperationalBristol-Myers Squibb is developing innovative treatments and supporting Cyprus' national effort in haematology.Moves AstraZeneca
-
GSK OperationalClement Fourny joins Biodextris as CEO, a company that originated as a GSK development center.Moves AstraZeneca
Connections
The 15 strongest of 22, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Pascal Soriot Structural
Pascal Soriot holds the role of Chief Executive Officer of AstraZeneca.
-
Morgan Stanley Operational
Morgan Stanley's analyst targets influence market perception and stock valuation of AstraZeneca.
-
Daiichi Sankyo Operational
AstraZeneca and Daiichi Sankyo are actively engaged in both co-developing drugs and competing in the HER2-mutant NSCLC treatment market.
-
Bristol-Myers Squibb Operational
The two companies are currently engaged in a collaborative partnership focused on developing advanced cancer drugs.
-
GSK Operational
GSK and AstraZeneca have formed a partnership to gain access to the mainland China market.
-
Merck KGaA Operational
The two companies actively compete against each other within the global pharmaceutical market.
-
FDA Structural
AstraZeneca seeks regulatory approval from the FDA for new products.
-
AstraZeneca Transactional
Acquired global rights to Dizal's Zegfrovy.
Show all 15 connections
-
Barclays Mentioned together
Both entities are noted as major listed companies in their respective global markets.
-
Iran Shared context
AstraZeneca's drug trials are constrained by geopolitical risks associated with Iran.
-
Alnylam Pharmaceuticals Operational
The relationship is characterized by competitive influence where clinical failures of rival drugs affect the risk profiles of both companies.
-
Citibank Mentioned together
Citibank provided a price target upgrade for AstraZeneca.
-
Ionis Pharmaceuticals Structural
Ionis Pharmaceuticals and AstraZeneca are formal partners in drug development, as evidenced by AstraZeneca's trial failure impacting the collaboration.
-
Deutsche Bank None
No evidence of a relationship between AstraZeneca and Deutsche Bank was found in the provided timeline.
-
gold Mentioned together
No direct relationship between AstraZeneca and gold was observed in the provided evidence.
History
Events by the month they beganAugust 2026
3 events- Corporate stocks, including AstraZeneca and CMG, reacted to analyst ratings and U.S. Treasury buyback plans.
- Bristol-Myers Squibb and AstraZeneca announced a collaboration on advanced cancer drug development.
- Barclays and AstraZeneca are noted as major listed companies amid positive market sentiment for miners and lenders.
July 2026
3 events- Citibank upgraded its price target while Deutsche Bank maintained a negative rating for AstraZeneca.
- A late-stage trial failure involving a partner of AstraZeneca was announced, while the FDA concurrently approved Tryngolza for severe hypertriglyceridemia.
- GSK and AstraZeneca announce a partnership aimed at gaining access to the mainland China market.